Drug Shortage Report for EPIRUBICIN HYDROCHLORIDE INJECTION

Last updated on 2018-07-26 History
Report ID 1081
Drug Identification Number 02264927
Brand name EPIRUBICIN HYDROCHLORIDE INJECTION
Common or Proper name EPIRUBICIN
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EPIRUBICIN HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 10mg/5mL x 1
ATC code L01DB
ATC description CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2014-10-14
Actual start date 2014-11-29
Estimated end date Unknown
Actual end date 2017-09-04
Shortage status Resolved
Updated date 2018-07-26
Company comments It has been discontinued (report ID 15441)
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-07-26 French Compare
v3 2018-07-26 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 4 of 4